X T L Biopharmaceuticals reported $8.55M in Assets for its fiscal quarter ending in December of 2024.


Assets Change Date
Alaunos Therapeutics USD 2.76M 795K Dec/2024
Bioline Rx USD 43.27M 240K Jun/2025
Teva Pharmaceutical Industries USD 40.13B 1.72B Jun/2025
X T L Biopharmaceuticals USD 8.55M 730K Dec/2024